Allworth Financial’s Antares Pharma, Inc. ATRS Stock Holding History

Allworth Financial’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-200	Closed	-$1K	–	1018
2018 Q2	$1K	Hold	200	–	–	﹤0.01%	915
2018 Q1	$0	Hold	200	–	–	﹤0.01%	885
2017 Q4	$0	Hold	200	–	–	﹤0.01%	830
2017 Q3	$1K	Buy	+200	New	+$617	﹤0.01%	721

Other funds holding ATRS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MWP

MYCIO Wealth Partners Philadelphia, Pennsylvania $502M AUM 11.65% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allworth Financial's ATRS Position: Q3 2018 in Review

Allworth Financial sold out of Antares Pharma, Inc. (ATRS) in Q3 2018, closing a stake of 200 shares — an estimated $1K sold.

Allworth Financial first reported a position in ATRS in Q3 2017 and held it in 4 quarters. The position peaked at $1K in Q2 2018. 105 funds tracked by Wall St. Rank hold ATRS as of Q3 2018.

Allworth Financial reported no remaining Antares Pharma, Inc. position as of Q3 2018 after selling out during the quarter.
Allworth Financial sold 200 Antares Pharma, Inc. shares in Q3 2018, an estimated $1K.
Allworth Financial first reported a position in Antares Pharma, Inc. in Q3 2017 and held it in 4 quarters.
Allworth Financial's Antares Pharma, Inc. position peaked at $1K in Q2 2018.
105 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2018.

Based on Allworth Financial's 13F filing for Q3 2018, filed 30 Oct 2018.